Upexi, Inc. (NASDAQ:UPXI) Sees Significant Drop in Short Interest

Upexi, Inc. (NASDAQ:UPXI) was the target of a significant decline in short interest in March. As of March 31st, there was short interest totalling 27,800 shares, a decline of 29.3% from the March 15th total of 39,300 shares. Approximately 2.7% of the shares of the stock are short sold. Based on an average daily volume of 131,100 shares, the days-to-cover ratio is presently 0.2 days.

Upexi Stock Down 7.6 %

Shares of Upexi stock opened at $2.30 on Friday. The firm’s 50-day moving average price is $2.71 and its two-hundred day moving average price is $3.80. The company has a current ratio of 0.58, a quick ratio of 0.53 and a debt-to-equity ratio of 0.35. Upexi has a 12-month low of $1.90 and a 12-month high of $15.91.

Upexi (NASDAQ:UPXI) last announced its quarterly earnings data on Friday, February 14th. The company reported ($1.24) earnings per share (EPS) for the quarter. The company had revenue of $4.01 million for the quarter.

Institutional Trading of Upexi

A hedge fund recently bought a new stake in Upexi stock. Bank of Montreal Can bought a new position in Upexi, Inc. (NASDAQ:UPXI) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 10,008 shares of the company’s stock, valued at approximately $36,000. Bank of Montreal Can owned about 0.81% of Upexi at the end of the most recent quarter. Institutional investors own 5.68% of the company’s stock.

About Upexi

Upexi, Inc manufactures and sells various branded products in the health, wellness, pet, beauty, and other markets. The company was formerly known as Grove, Inc and changed its name to Upexi, Inc in August 2022. The company was incorporated in 2018 and is headquartered in Clearwater, Florida.